Erytech Pharma S.A. (ERYP) News
Filter ERYP News Items
ERYP News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ERYP News Highlights
- For ERYP, its 30 day story count is now at 7.
- Over the past 22 days, the trend for ERYP's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- DRUG, MA and COMP are the most mentioned tickers in articles about ERYP.
Latest ERYP News From Around the Web
Below are the latest news stories about ERYTECH PHARMA SA that investors may wish to consider to help them evaluate ERYP as an investment opportunity.
ERYTECH announces that the Commercial Court has rejected Akkadian's request to postpone the vote on the merger with Pherecydes PharmaERYTECH announces that the Commercial Court has rejected Akkadian's request to postpone the vote on the merger with Pherecydes Pharma Cambridge, MA (U.S.) and Lyon (France), June 14, 2023, 8:00 pm CEST – ERYTECH Pharma (Nasdaq & Euronext: ERYP), announced today that the Lyon Commercial Court has rejected Akkadian's request to postpone the vote on the merger with Pherecydes Pharma. Erytech is pleased with today's order delivered by the President of the Lyon Commercial Court. This order rejected A |
Erytech's Battle With Activist Investor Echoes As Pherecydes Pharma Merger Vote Comes CloserIn February, Erytech Pharma SA (NASDAQ: ERYP) announced its proposed combination with Pherecydes Pharma S.A. In June, Erytech announced that Akkadian initiated proceedings to postpone the vote, scheduled on 23 June, on the merger with Pherecydes. The merger would see Pherecydes absorbed into publicly listed Erytech, with Pherecydes shareholders receiving 15 new Erytech shares for every four of their current shares. Monday, Erytech Pharma responded to what it described as Akkadian Partners' "disi |
Monthly information related to total number of voting rights and shares composing the share capital _May 31, 2023Monthly information related to total number of voting rights and shares composing the share capital _May 31, 2023. Article 223-16 of general regulation of French Autorité des Marchés FinanciersLyon – France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP)Website : www.erytech.com DateTotal of shares composing the share capitalTotal of brut (1) voting rightsTotal of net (2) v |
ERYTECH Responds to Akkadian’s DisinformationERYTECH Responds to Akkadian’s Disinformation Akkadian’s challenge of the merger is based on incomplete information and misleading argumentsAkkadian has not presented any valuable alternative optionAkkadian’s unfounded actions present a risk of destruction of shareholder value and loss of employment at two companies, and the potential loss of a strategically important technology in FranceIn this context, ERYTECH reminds its shareholders of the importance of participating in the Annual General Me |
ERYTECH announces that Akkadian has initiated proceedings to postpone the vote on the merger with PherecydesERYTECH announces that Akkadian has initiated proceedings to postpone the vote on the merger with Pherecydes Cambridge, MA (U.S.) and Lyon (France), June 5, 2023 – ERYTECH Pharma (Nasdaq & Euronext: a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that Akkadian Partners has initiated legal proceedings to obtain the postponement of the vote on the merger with Pherecydes at the Annual Gen |
ERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 23, 2023ERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 23, 2023 Cambridge, MA (U.S.) and Lyon (France), May 24, 2023 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced the availability of the documents for its Annual General Meeting to be held on Friday, June 23, 2023. ERYTECH’s shareholders are her |
ERYTECH announces the availability of the exemption document relating to the proposed combination with PherecydesPRESS RELEASE ERYTECH announces the availability of the exemption document relating to the proposed combination with Pherecydes Lyon (France), May 23, 2023 - ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it has published the exemption document relating to the proposed combination with Pherecydes. The document may be consulted on the comp |
Monthly information related to total number of voting rights and shares composing the share capital _May 15, 2023Monthly information related to total number of voting rights and shares composing the share capital _May 15, 2023. Article 223-16 of general regulation of French Autorité des Marchés FinanciersLyon – France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) & Nasdaq Global Select Market in the United-States (Symbol : ERYP)Website : www.erytech.com DateTotal of shares composing the share capitalTotal of brut (1) voting rightsTotal of net (2) v |
ERYTECH Provides Update on the Announced Combination with PHERECYDESERYTECH Provides Update on the Announced Combination with PHERECYDES Entry into a definitive merger agreement between ERYTECH and PHERECYDESCompletion of a contribution in kind of PHERECYDES shares to ERYTECHCombination with PHERECYDES to be submitted to shareholders' vote on June 23, 2023 Lyon (France) and Cambridge (MA, US), May 15, 2023 – ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug subst |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayIt's time for another dive into the biggest pre-market stock movers traders need to know about as we cover the winners and losers for Friday! |